In recent years, the world has witnessed a profound cultural and scientific shift in the perception and understanding of psychedelics.

      A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve

      A new article in the Journal of the American Medical Association (JAMA) suggests that state-regulated psychedelics are on a collision

      The campaign behind a prospective California ballot initiative to legalize psychedelics filed a final revised measure with state officials this

      Bipartisan and bicameral congressional lawmakers have reached an agreement on a large-scale defense bill that contains a House GOP-led section

      The push toward mainstream legitimacy is largely what’s fueled the rise in dealmaking. Business deals, partnerships, and mergers in the

      Massachusetts activists say local election clerks across the state have certified that they turned in more than enough valid signatures

      The company expects to launch a Phase 2 study in the first quarter of 2024. Gilgamesh Pharmaceuticals announced the successful

      Table of Contents Yarixa Ferrao, a 42-year-old in Los Angeles, was working as a personal trainer when she injured her